Cellect (APOP) Reports First Successful Stem Cell Transplant Procedure Using its ApoGraft Technology – StreetInsider.com
|
Cellect (APOP) Reports First Successful Stem Cell Transplant Procedure Using its ApoGraft Technology
StreetInsider.com Cellect Biotechnology Ltd. (Nasdaq: APOP) announced today that the first stem cell transplant procedure has been successfully performed using its ApoGraft™ technology in the Company's Phase I/II clinical trial in a blood cancer patient. Up to 50 … |
